(The Epoch Times)—A top Food and Drug Administration (FDA) official said on May 15 that she never took a COVID-19 vaccine due to concerns about biodistribution.
Dr. Sara Brenner, the FDA’s principal deputy commissioner, said during an event in Washington that she did not receive any of the COVID-19 vaccines.
Brenner said that she was pregnant during the COVID-19 pandemic.
“It was unknown at the time what the biodistribution patterns of those products were, and in my case, in particular, what the excretion would be in breast milk,” Brenner said. “That was my primary concern, and that exposure I was very concerned about.”
When asked whether the information that has emerged since then validates her choice, Brenner, who said she was not speaking on behalf of the FDA, said she thinks it does.
Researchers reported in a 2022 paper that messenger ribonucleic acid, which is in the Pfizer and Moderna COVID-19 shots, was detected in human breast milk. Another paper, in 2023, detailed similar findings.
Pfizer and Moderna did not return requests for comment.
Dr. Marty Makary, the FDA’s commissioner, has been critical of COVID-19 vaccine boosters. He has indicated that he received a primary series of one of the vaccines.
About 81 percent of the U.S. population received at least one dose of a COVID-19 vaccine as of the spring of 2023, according to federal data.
Brenner was speaking at an event held by a new group that is seeking to help influence officials such as Health Secretary Robert F. Kennedy Jr. and their promotion of an agenda dubbed Make America Healthy Again (MAHA). The group is called the MAHA Institute.
The comments came on the same day a health official confirmed to The Epoch Times that officials will stop recommending routine COVID-19 vaccination for youth and pregnant women. The Centers for Disease Control and Prevention, which, like the FDA, is part of the Department of Health and Human Services, currently recommends that people aged 6 months and older receive at least one dose of the currently available vaccines.
Brenner, who has trained as a preventative medicine doctor and has expertise in nanotechnology, has been with the FDA since the first Trump administration. She was the agency’s chief medical officer for diagnostics during the pandemic and was detailed to support White House efforts to respond to COVID-19 while Joe Biden was president.
Brenner recalled conducting toxicology research while in school, including examining biodistribution. She said that an important part of medicine is looking at the unintended effects, also known as adverse events or side effects. She also said she knew that the lipid nanoparticles used to deliver mRNA in the COVID-19 vaccines could result in unintended effects.
Brenner referred to previous years in the government as a dark time, but described the present day as a new dawn, with fresh leaders such as Kennedy in place.
“We’re moving very quickly to make it such that there will be more transparency, more available data and information, so that people … can see and evaluate for themselves sort of what the truths are and what’s known and unknown,” she said. “And I’ll go ahead and put it that way, because one of the biggest misses, I think, in the previous several years is that there was no acknowledgement of what was unknown, right? There was there were only statements and assertions that were really more like beliefs or things that were desired to be true than they were true knowns.”
Brenner said that a key part of regaining trust from the public is being honest and transparent. She also said she believes that the vast majority of government workers are good people who want to serve their country and try to do their best, and that it will take a long time to figure out how events unfolded during the pandemic.
- Hand-curated links from conservative and Christian sites — NO legacy media garbage links. Patriots get their news every day at JDRucker.com
Bypass Big Tech Censors
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.
